Work

Preclinical efficacy of PR115002, a novel sortilin-targeting peptide-drug conjugate, in platinum-resistant ovarian cancer.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17559

Authors: Jingfang Wang, Ying Wang, Zhidong Song, Weikang Ling, Siyu Tong, Hansi Zhang, Cheng Peng

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410813465

FWCI:

Cites:

Cited by:

Related to: 10